AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey Pox
By M. Marin
NASDAQ:AEMD
READ THE FULL AEMD RESEARCH REPORT
BCLI: Filing a BLA for NurOwn® for the Treatment of ALS…
By David Bautz, PhD
NASDAQ:BCLI
READ THE FULL BCLI RESEARCH REPORT
NOVN: EPI Revenue Trends Are Strong
By John Vandermosten, CFA
NASDAQ:NOVN
READ THE FULL NOVN RESEARCH REPORT
DYAI: Dapibus on the Menu
By John Vandermosten, CFA
NASDAQ:DYAI
READ THE FULL DYAI RESEARCH REPORT
MDNA: Unconfirmed Partial Response in Pancreatic Cancer Patient…
By David Bautz, PhD
NASDAQ:MDNA
READ THE FULL MDNA RESEARCH REPORT
LGVN: Quarterly Report Provides Good News
By Brad Sorensen, CFA
NASDAQ:LGVN
READ THE FULL LGVN RESEARCH REPORT
CXW: Delays in La Palma Transition & Title 42 Reversal Mask Underlying Strength
By M. Marin
NYSE:CXW
READ THE FULL CXW RESEARCH REPORT
ECOR: Consistent Expansion of Distribution
By John Vandermosten, CFA
NASDAQ:ECOR
READ THE FULL ECOR RESEARCH REPORT
ARWR: Phase 1/2a Clinical Trials Underway for Pulmonary Disease Candidates…
By David Bautz, PhD
NASDAQ:ARWR
READ THE FULL ARWR RESEARCH REPORT
TRC: Large Land Sale Post-2Q22, Debt Maturities Extended
By M. Marin
NYSE:TRC
READ THE FULL TRC RESEARCH REPORT